The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

Hepatitis B and C (HBV/HCV) coinfected patients have a potential risk of hepatitis B reactivation (HBVr) after direct-acting antivirals (DAAs) treatment. The study intends to investigate the predictive role of HBV biomarkers in HBVr. Forty-six HBV/HCV coinfected patients receiving DAAs were enrolled...

Full description

Bibliographic Details
Main Authors:	Chih-Wei Tseng, Wen-Chun Liu, Ping-Hung Ko, Yen-Chun Chen, Kuo-Chih Tseng, Ting-Tsung Chang
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Viruses
Subjects:	hepatitis B surface antigen hepatitis B core-related antigen HBV pregenomic RNA hepatitis C HBV/HCV coinfection direct-acting antiviral
Online Access:	https://www.mdpi.com/1999-4915/14/8/1812

Similar Items

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
by: Chih-Wei Tseng, et al.
Published: (2022-04-01)

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
by: Maryam Moini, et al.
Published: (2022-03-01)

Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection
by: Yayun Liu, et al.
Published: (2019-04-01)

HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy
by: Antonio Salvio, et al.
Published: (2012-01-01)

Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen
by: Mary C. Kuhns, et al.
Published: (2021-10-01)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
by: Janine Hartl, et al.
Published: (2012-07-01)

The Hepatitis B Surface Antigen Binding Protein: An Immunoglobulin G Constant Region-Like Protein That Interacts With HBV Envelop Proteins and Mediates HBV Entry
by: Yeping Sun, et al.
Published: (2018-09-01)

HBV-DNA in hemodialysis patients infected by HCV
by: Arababadi Mohammad, et al.
Published: (2009-01-01)

Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
by: El-Araby Mohamed Ibrahim Shalaby, et al.
Published: (2023-06-01)

Recent Advances in HBV and HCV Immunology
by: Lynn B Dustin, et al.
Published: (2015-09-01)

Dynamics of Serum Pregenome RNA in Chronic Hepatitis B Patients Receiving 96-Month Nucleos(t)ide Analog Therapy
by: Yachao Tao, et al.
Published: (2022-02-01)

Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy
by: Cesare Mazzaro, et al.
Published: (2022-10-01)

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection
by: Keeffe Emmet B, et al.
Published: (2005-09-01)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
by: Yael Gozlan, et al.
Published: (2022-03-01)

Diagnostic precision of Truenat® technique and co-relation of ALT levels with HBV-DNA viral load among HBsAg positive patients at a tertiary care hospital in Eastern Uttar Pradesh
by: Sarita Kumari, et al.
Published: (2024-02-01)

Editorial: HBV and lymphoma
by: Giuseppe Gentile, et al.
Published: (2023-07-01)

Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
by: Yu-Chan Yang, et al.
Published: (2021-12-01)

Seroprevalence and risk factors of HBV, HCV and HIV among hemodialysis patients: a multicenter cross-sectional study from Damascus Syria
by: Jehan Altinawe, et al.
Published: (2024-03-01)

Occult HBV Infection in Patients Infected by HIV or HCV: Comparison between HBV-DNA and Two Assays for HBsAg
by: Silvia Meschi, et al.
Published: (2024-03-01)

Treatment of patients with HBV cirrhosis: Successes, unsolved problems
by: I G Bakulin, et al.
Published: (2013-12-01)

Epidemiological Survey of the Prevalence of HCV and HBV among the Factory Workers in the Periphery of Lahore
by: Muhammad Khurram, et al.
Published: (2021-05-01)

Management of Chronic Hepatitis B in HIV-Coinfected Patients
by: Massimo Fasano, et al.
Published: (2022-09-01)

Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss
by: I-Chin Wu, et al.
Published: (2021-05-01)

HBV Infection in HIV-Driven Immune Suppression
by: Loredana Sarmati, et al.
Published: (2019-11-01)

Effect of Anti-HBs on Mortality Among Resolved HBV Infection: a Population-Based Prospective Cohort Study
by: Shuai-Wen Huang, et al.
Published: (2023-02-01)

Comparison of HBV-DNA Levels with Biochemical and Microbiological Parameters for Chronic Hepatitis Evaluation, Bursa, Turkey
by: Sanem Karadag Gecgel
Published: (2021-03-01)

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
by: Erik De Clercq, et al.
Published: (2010-05-01)

Current Challenges and Future Perspectives of Diagnosis of Hepatitis B Virus
by: Manoj Kumar, et al.
Published: (2023-01-01)

HBV profile of the occult HBV infection in blood donors at Maharaj Nakorn Chiang Mai Hospital
by: Nipapan Leetrakool, et al.
Published: (2013-01-01)

Characteristics of patients with Hepatitis B and C at Dr. Moewardi General Hospital in Surakarta, Indonesia
by: Benedictus Aditya Satya Laksana Adji, et al.
Published: (2022-11-01)

The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing
by: Ying Wang, et al.
Published: (2021-11-01)

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
by: Byung-Cheol Song, et al.
Published: (2014-12-01)

Profile of HIV subtypes in HIV/HBV- and HIV/HCV-coinfected patients in Southern Brazil
by: Valéria Miranda Avanzi, et al.

HIV/HBV Coinfection with HBsAg Seroconversion: A Case Report
by: Yasemin ÇAKIR, et al.
Published: (2024-03-01)

Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy
by: Piero Colombatto, et al.
Published: (2022-03-01)

[Use of tenofovir monotherapy in a cohort of prisoners confined in the prisons of the Molise region and affected by mild HBV-related chronic hepatitis]
by: Roberto Patriarchi, et al.
Published: (2015-12-01)

Seroprevalence of hepatitis B virus surface antigen (HBsAg) in Egypt (2000–2022): a systematic review with meta-analysis
by: Ahmed Azzam, et al.
Published: (2023-03-01)

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
by: Young-Suk Lim
Published: (2023-01-01)

Serum O-glycosylated hepatitis B surface antigen levels in patients with chronic hepatitis B during nucleos(t)ide analog therapy
by: Ayato Murata, et al.
Published: (2022-05-01)

Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy
by: Shida Pan, et al.
Published: (2022-05-01)